Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sunrise Medical ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   3.3% 4.3% 3.4% 1.3% 0.9% 0.7% 14.1% 14.1%   Credit score (0-100)   57 49 54 79 88 94 16 16   Credit rating   BBB BBB BBB A A AA BB BB   Credit limit (kDKK)   0.0 0.0 0.0 113.9 588.3 1,117.2 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,924 9,502 9,992 10,809 11,739 12,726 0.0 0.0   EBITDA   5.1 -406 1,323 1,438 1,816 2,186 0.0 0.0   EBIT   -2,450 -2,832 -404 1,247 1,700 2,097 0.0 0.0   Pre-tax profit (PTP)   -2,839.7 -3,273.0 -622.0 857.4 1,408.5 1,921.2 0.0 0.0   Net earnings   -2,839.7 -3,273.0 -622.0 857.0 1,408.5 1,921.2 0.0 0.0   Pre-tax profit without non-rec. items   -2,840 -3,273 -622 857 1,409 1,921 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   176 353 297 249 133 43.3 0.0 0.0   Shareholders equity total   3,492 3,015 2,400 3,257 4,666 6,587 -8,413 -8,413   Interest-bearing liabilities   9,990 3,628 2,266 7,893 6,254 4,232 8,452 8,452   Balance sheet total (assets)   17,305 13,635 11,615 15,133 14,867 14,990 39.0 39.0   Net Debt   7,234 -855 -398 5,438 4,773 575 8,452 8,452     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,924 9,502 9,992 10,809 11,739 12,726 0.0 0.0   Gross profit growth   -5.0% -13.0% 5.2% 8.2% 8.6% 8.4% -100.0% 0.0%   Employees   20 19 16 16 16 16 0 0   Employee growth %   0.0% -5.0% -15.8% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   17,305 13,635 11,615 15,133 14,867 14,990 39 39   Balance sheet change%   -2.4% -21.2% -14.8% 30.3% -1.8% 0.8% -99.7% 0.0%   Added value   5.1 -406.5 1,322.5 1,438.4 1,891.6 2,186.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -4,816 -4,531 -3,371 -239 -232 -140 -43 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -22.4% -29.8% -4.0% 11.5% 14.5% 16.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -13.4% -17.2% -3.1% 9.4% 12.4% 14.7% 0.0% 0.0%   ROI %   -17.1% -26.5% -7.0% 15.8% 16.8% 20.2% 0.0% 0.0%   ROE %   -57.8% -100.6% -23.0% 30.3% 35.6% 34.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   20.3% 22.2% 20.9% 21.5% 31.6% 44.1% -99.5% -99.5%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   141,324.9% 210.3% -30.1% 378.0% 262.8% 26.3% 0.0% 0.0%   Gearing %   286.1% 120.3% 94.4% 242.3% 134.1% 64.3% -100.5% -100.5%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 8.9% 7.8% 7.8% 6.4% 5.3% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 0.6 0.6 0.7 1.0 0.0 0.0   Current Ratio   0.9 1.0 1.2 1.2 1.4 1.8 0.0 0.0   Cash and cash equivalent   2,755.1 4,482.7 2,663.5 2,454.8 1,481.0 3,657.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,399.5 485.6 1,513.8 2,668.0 4,161.1 6,233.3 -4,226.0 -4,226.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -21 83 90 118 137 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -21 83 90 114 137 0 0   EBIT / employee   -123 -149 -25 78 106 131 0 0   Net earnings / employee   -142 -172 -39 54 88 120 0 0